Impact of Low-Level Laser Therapy on Hair Regrowth Post PRP Treatment
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Superior University
- Enrollment
- 22
- Locations
- 2
- Primary Endpoint
- Physician's Global Assessment (PGA) scale
Study Overview
Brief Summary
Low-level laser stimulates cells in the hair follicles, which promotes hair growth. The patient's own blood platelets are used in platelet-rich plasma treatment to encourage hair growth. Combining low-level laser treatment with platelet-rich plasma will promote hair growth in patients.
Detailed Description
To determine the impact of low-level laser therapy on hair regrowth following prp treatment.
This will be case control study conducted on 22 participants with androgenetic alopecia (AGA).
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to 35 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Adults between 18-35 years diagnosed with androgenic alopecia or other non-scarring hair loss conditions.
- •Having the Norwood-Hamilton scale placed in stages I-V for men Ludwig scale in stages I-III for women .
Exclusion Criteria
- •Use of systemic medications (e.g., corticosteroids, immunosuppressants) or treatments affecting hair regrowth within the last 3 months.
- •History of hypersensitivity or adverse reactions to laser therapy
- •Active systemic diseases such as uncontrolled diabetes, autoimmune disorders, or malignancies
- •Pregnant or breastfeeding individuals.
- •Patients with pacemakers or implanted medical devices contraindicated with low level laser therapy.
- •History of hair transplant surgery in the treatment area
Arms & Interventions
low leve laser therapy post prp treatment
Intervention: low level laser therapy post prp treatment (Combination Product)
PRP treatment
Intervention: PRP treatment (Combination Product)
Outcomes
Primary Outcomes
Physician's Global Assessment (PGA) scale
Time Frame: 12 Months
The Physician's Global Assessment (PGA) scale is a tool used by physicians to evaluate the overall severity of a patient's disease. It's a subjective assessment, typically on a scale of 0 to 3 or 0 to 4, with higher scores indicating more severe disease activity. The PGA focuses on the overall disease activity, considering both the severity of active manifestations and relevant laboratory results, excluding organ damage and subjective findings unrelated to disease activity
Secondary Outcomes
No secondary outcomes reported
Investigators
Muhammad Naveed Babur
Principal Investigator
Superior University